Digital

Interview | Tracy Doyle, Phoenix Group

Interview | Tracy Doyle, Phoenix Group

By

Tracy Doyle, CEO of Phoenix Group, describes how the speakers bureau is evolving in a digital economy, including opportunities related to advancing content using virtual reality and augmented reality, and the potential for using OTT and artificial intelligence to drive peer-to-peer engagement. This video is presented by Phoenix Group and produced by the MM&M Content Lab.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

Sanofi revamps web presence as part of Empowering Life campaign

Sanofi revamps web presence as part of Empowering Life campaign

By

The company is also looking to better combine its web and social media presence.

Capgemini expands digital chops with LiquidHub acquisition

Capgemini expands digital chops with LiquidHub acquisition

By

LiquidHub formed a health- and life-sciences-focused offering last June after acquiring Eveo.

Goodbye, YouTube. Regulations could prompt  microinfluencer migration to other platforms

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

By

Some microinfluencers see the latest YouTube guidelines as a "slap in the face."

McCann Health promotes Marcus Sigurdsson to global chief digital officer

McCann Health promotes Marcus Sigurdsson to global chief digital officer

By

Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.

What Facebook's news feed changes mean for brands and publishers

What Facebook's news feed changes mean for brands and publishers

By

Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.

Five things for pharma marketers to know: Friday, January 12, 2018

Five things for pharma marketers to know: Friday, January 12, 2018

By

Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

By

The founder of Stagwell has claimed digital marketing agencies are undervalued because investors still fail to appreciate how much digital communications and e-commerce are going to transform the economy.

MM&M's 5 most-read technology stories of 2017

MM&M's 5 most-read technology stories of 2017

By

Digital innovation in Japan, health-tech trends, and social media top the list.

Five things for pharma marketers to know: Wednesday, December 27, 2017

Five things for pharma marketers to know: Wednesday, December 27, 2017

By

Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition

TAG-certified channels have 83% fewer incidences of ad fraud

TAG-certified channels have 83% fewer incidences of ad fraud

By

A study has found that channels certified by the Trustworth Accountability Group (TAG) had 83% less ad fraud than the broader industry average.

GroupM unveils upbeat global adspend forecast for 2018

GroupM unveils upbeat global adspend forecast for 2018

By

GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.

Facebook explains advertising policies to its users but industry wants more

Facebook explains advertising policies to its users but industry wants more

By

Facebook has formally outlined is advertising policies to its users but the industry feels the internet giant is offloading responsibility instead of stepping up.

Up to 20% of pharma brands moving digital media spend to point-of-care

Up to 20% of pharma brands moving digital media spend to point-of-care

By

Two point-of-care companies have received hundreds of millions of dollars in funding. One of them, Outcome Health, is facing allegations about padding data.

Drugmakers begin to up media controls, in bid to clean up digital ad supply

Drugmakers begin to up media controls, in bid to clean up digital ad supply

By

Like its consumer-products cousins, pharma marketers are exercising more discipline over online media. Will it yield similar results?

One-quarter of global marketers report digital ads next to extremist content

One-quarter of global marketers report digital ads next to extremist content

By

Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

By

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Shutterstock says men are 'more responsive' to online ads

Shutterstock says men are 'more responsive' to online ads

By

Images that "mirror the demographic profile of their target audience" perform best, according to an eye-tracking study from picture provider Shutterstock.

Otsuka, Proteus refile their sensor-enabled drug

Otsuka, Proteus refile their sensor-enabled drug

By

The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.

Five things for pharma marketers to know: Wednesday, May 17, 2017

Five things for pharma marketers to know: Wednesday, May 17, 2017

By

FDA requires boxed warning for J&J's Invokana; Amazon to reportedly hire GM to enter pharmacy industry; WannCry ransomware affects some health organizations

Renee Rodgers, Novartis

Renee Rodgers, Novartis

Renee Rodgers is executive director and head of digital strategy for U.S. oncology at Novartis.

Lisa Flaiz, formerly of Janssen

Lisa Flaiz, formerly of Janssen

Lisa Flaiz is the former group product director of digital marketing at Janssen.

Bruno Villetelle, Takeda Pharmaceutical

Bruno Villetelle, Takeda Pharmaceutical

Bruno Villetelle is chief digital officer at Takeda Pharmaceutical.

Kristin Milburn, Novartis

Kristin Milburn, Novartis

Kristin Milburnis head of strategic partnerships and the digital acceleration lab at Novartis.

Matias Coo, Avanir

Matias Coo, Avanir

Matias Coo is director of digital marketing for Avanir.

The 2017 DTC Report: All the data in one place

The 2017 DTC Report: All the data in one place

Drugmakers again spent more on DTC advertising in 2016 than the year before.

Digital IDs become focus as drugmakers seek to track doctors' behavior online

Digital IDs become focus as drugmakers seek to track doctors' behavior online

By

Organizations are focusing on better ways to verify HCPs' digital identities.

MM&M conference to explore beyond-the-pill

MM&M conference to explore beyond-the-pill

By

The MM&M Transforming Healthcare Conference will be held May 1 in New York City.

Why Pharma Refuses to See Value in 'Influence'

Why Pharma Refuses to See Value in 'Influence'

At the very least, pharma marketers need to make sure they know the difference between search engine marketing and search engine optimization.